Godrej Consumer Products
- P/E
- 45.38
Key Fundamentals
MidcapPersonal ProductsFMCGPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 18.80%
- Debt to Equity
- 0.35
- EPS (TTM)
- ₹18.71
- Book Value
- ₹123.29
- Market Cap
- —
- P/E (TTM)
- 45.38
- P/B
- 6.89
- ROE
- 16.10%
- Dividend Yield
- 1.82%
- EBITDA
- ₹3,422 Cr
- 52W High
- ₹1,273.90
- 52W Low
- ₹777.20
- Day Range
- ₹824.30 – ₹851.20
- Volume
- 18,98,029
Peer Comparison
Fast Moving Consumer Goods › Consumer Goods › Personal Care
| ₹849.00 | 45.38 | ₹86,648 Cr | 6.89 | 1.82% | 16.10% | 18.80% | ₹15,949 Cr | ₹1,914 Cr | |
| ₹395.00 | 35.52 | ₹69,681 Cr | 6.14 | 2.16% | 17.00% | 20.30% | ₹13,552 Cr | ₹1,947 Cr | |
| ₹1,660.70 | 33.17 | ₹45,422 Cr | 27.92 | 1.47% | 82.70% | 108.00% | ₹6,391 Cr | ₹1,362 Cr | |
| ₹336.50 | 329.90 | ₹44,683 Cr | 100.45 | 1.48% | 27.60% | 33.90% | ₹484 Cr | ₹137 Cr | |
| ₹7,527.00 | 36.71 | ₹23,745 Cr | 25.92 | 3.32% | 66.50% | 90.70% | ₹3,176 Cr | ₹668 Cr | |
| ₹6,959.00 | 28.57 | ₹22,555 Cr | 29.98 | 3.61% | 115.00% | 157.00% | ₹4,245 Cr | ₹790 Cr | |
| ₹381.35 | 22.24 | ₹16,773 Cr | 5.69 | 2.62% | 26.20% | 28.10% | ₹3,915 Cr | ₹749 Cr | |
| Median 7 companies | ₹849.00 | 35.52 | ₹44,683 Cr | 25.92 | 2.16% | 27.60% | 33.90% | ₹4,245 Cr | ₹790 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 73
- Strong
- Returns, margins, earnings quality 22% weight
- Valuation
- 33
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 50
- Average
- Sales & profit trajectory 9% weight
- Financial Health
- 71
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 26
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 52
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
No strengths listed
Weaknesses
4- Stock is trading at 7.05 times its book value
- The company has delivered a poor sales growth of 6.60% over past five years.
- Company has a low return on equity of 13.8% over last 3 years.
- Promoter holding has decreased over last 3 years: -10.2%
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bearish | 8 | 5 | 6 |
| Oscillators | Neutral | 2 | 5 | 2 |
| Moving Averages | Strong Bearish | 6 | 0 | 4 |
Oscillators
Neutral
Overall
Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 48.83
- Neutral
- MACD (12,26,9)
- −12.29
- Bullish
- SMA (50)
- 867.09
- Bearish
- SMA (200)
- 1,026.10
- Bearish
As of
Analyst Rating
25 of 33 analysts rate Buy, 7 Hold, 1 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +6.06% |
|---|---|
| 5Y | +6.59% |
| 3Y | +4.46% |
| 1Y | +8.44% |
| TTM | +9.16% |
Net profit
| 10Y | +8.40% |
|---|---|
| 5Y | +1.58% |
| 3Y | +3.02% |
| 1Y | +0.49% |
| TTM | +3.29% |
Operating cash flow
| 10Y | +11.38% |
|---|---|
| 5Y | +4.15% |
| 3Y | +4.97% |
| 1Y | −3.45% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | +1.21 pp |
|---|---|
| 5Y | −0.87 pp |
| 3Y | +2.53 pp |
| 1Y | −0.66 pp |
| TTM | +0.08 pp |
Revenue by year
| Mar 2017 | ₹9,268 Cr |
|---|---|
| Mar 2018 | ₹9,847 Cr |
| Mar 2019 | ₹10,314 Cr |
| Mar 2020 | ₹9,911 Cr |
| Mar 2021 | ₹11,029 Cr |
| Mar 2022 | ₹12,276 Cr |
| Mar 2023 | ₹13,316 Cr |
| Mar 2024 | ₹14,096 Cr |
| Mar 2025 | ₹13,997 Cr |
| Mar 2026 | ₹15,178 Cr |
Net profit by year
| Mar 2017 | ₹1,308 Cr |
|---|---|
| Mar 2018 | ₹1,634 Cr |
| Mar 2019 | ₹2,342 Cr |
| Mar 2020 | ₹1,497 Cr |
| Mar 2021 | ₹1,721 Cr |
| Mar 2022 | ₹1,783 Cr |
| Mar 2023 | ₹1,702 Cr |
| Mar 2024 | −₹561 Cr |
| Mar 2025 | ₹1,852 Cr |
| Mar 2026 | ₹1,861 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Godrej Consumer Products Ltd trades at ₹818 as of 2026-10-30 with a market cap of ₹83,706 Cr and a PE of 43.72x on a TTM EPS of ₹18.71. The stock is down 36% from its 52-week high of ₹1,273.9 and sits just 5% above its 52-week low of ₹777.2, reflecting a period of significant de-rating amid modest single-digit revenue and profit growth.
- ROCE of 21.44% indicates efficient capital deployment, comfortably above cost of capital for most FMCG businesses
- Debt-to-equity ratio of just 0.35 signals a conservatively leveraged balance sheet, providing financial flexibility for acquisitions or organic investment
- TTM sales growth has accelerated to 9%, above the 5-year compounded sales CAGR of 7% and the 3-year CAGR of 4%, suggesting improving revenue momentum
- TTM profit growth of 9% also exceeds the 5-year compounded profit CAGR of 3% and 3-year CAGR of 5%, indicating margin recovery or operating leverage kicking in
- The stock trades only 5% above its 52-week low of ₹777.2, meaning much of the negative sentiment may already be priced in after a 36% decline from the 52-week high of ₹1,273.9
- 10-year compounded sales CAGR of 6% and profit CAGR of 6% demonstrate long-term consistency and business durability across economic cycles
- Last year ROE of 16% shows improvement over the 3-year average of 14%, pointing to a potential inflection in return ratios
- PE of 43.72x is elevated for a company delivering only 9% TTM earnings growth, implying the stock still prices in substantial future acceleration
- Price-to-book of 6.62x (flagged at 7.05x on certain calculations) is high, and ROE of 14.71% does not adequately justify such a premium valuation
- 3-year ROE averages just 14%, and the flagged 13.8% over three years suggests sub-par capital efficiency for a premium consumer goods franchise
- Promoter holding has decreased by 10.2% over the last three years, a notable reduction that may signal reduced promoter confidence or dilution-related events
- 5-year compounded sales growth of only 7% and the flagged 6.6% is weak for a mid-to-large cap FMCG company operating across multiple geographies
- Stock CAGR is -23% over 1 year, -4% over 3 years, and -3% over 5 years, meaning shareholders have experienced negative wealth creation across multiple time horizons
- 5-year compounded profit CAGR of just 3% implies that earnings growth has significantly lagged revenue growth over a meaningful period, pointing to margin or cost pressures
- 10-year ROE has declined from 18% to the current 14.71%, indicating a structural deterioration in return profile over the long term
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Godrej Consumer Products is delivering strong top-line momentum led by its Indonesia and GAUM businesses, with high-teens revenue growth and double-digit EBITDA growth in Q2FY27. The new Indonesia plant adds 15% capacity for future regional expansion. Key risks include a 100-150 bps drag from standalone trade inventory correction and rising commodity costs. The international growth trajectory is clearly improving, but standalone India performance bears watching in the near term.
- Standalone trade inventory correction Oct 6
Standalone segment faces a 100-150 bps impact from trade inventory correction in Q2FY27, partially offsetting consolidated momentum.
- Rising commodity cost pressure Oct 6
Commodity costs are rising, though the company has maintained double-digit EBITDA growth so far despite the headwind.
- High-teens Q2 revenue growth Oct 6
Godrej Consumer expects high-teens consolidated revenue growth in Q2FY27, driven by strong volume and revenue expansion in Indonesia and GAUM businesses.
- New CEO approved overwhelmingly Oct 7
Shareholders approved Aasif Malbari as MD & CEO with 99.32% votes in favour via postal ballot, ensuring leadership continuity.
- Indonesia plant phase one live Oct 6
First phase of the new Kendal, Indonesia manufacturing facility inaugurated with an investment of IDR 500 billion (~INR 250 crore), expanding home and personal care capacity by approximately 15%.
- Indonesia capacity utilization 75-80% Oct 6
Current capacity utilization at the Indonesia operations stands at 75-80%, with the new plant aimed at meeting rising regional demand and enabling regional exports.
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,449 | 3,602 | 3,660 | 3,386 | 3,332 | 3,666 | 3,768 | 3,514 | 3,662 | 3,825 | 3,998 | 3,900 | 4,225 | 4,413 |
| Expenses | 2,806 | 2,898 | 2,819 | 2,630 | 2,607 | 2,907 | 3,012 | 2,755 | 2,967 | 3,092 | 3,118 | 3,059 | 3,424 | 3,593 |
| Operating Profit | 643 | 704 | 841 | 756 | 724 | 760 | 756 | 759 | 695 | 733 | 880 | 841 | 801 | — |
| OPM % | 19% | 20% | 23% | 22% | 22% | 21% | 20% | 22% | 19% | 19% | 22% | 22% | 19% | — |
| Other Income | −13 | 53 | 63 | −2,312 | 57 | 80 | 77 | 42 | 65 | 33 | −35 | −24 | 36 | — |
| Interest | 74 | 77 | 67 | 78 | 88 | 83 | 90 | 90 | 86 | 76 | 79 | 90 | 86 | 87 |
| Depreciation | 76 | 61 | 54 | 50 | 49 | 50 | 62 | 73 | 59 | 66 | 66 | 76 | 75 | 78 |
| PBT | 480 | 619 | 783 | −1,684 | 644 | 707 | 682 | 639 | 614 | 625 | 700 | 651 | 677 | 696 |
| Tax % | 34% | 30% | 26% | 12% | 30% | 30% | 27% | 36% | 26% | 27% | 29% | 31% | 25% | 25% |
| Net Profit | 319 | 433 | 581 | −1,893 | 451 | 491 | 498 | 412 | 452 | 459 | 498 | 452 | 505 | 523 |
| EPS (₹) | 3.12 | 4.23 | 5.68 | −18.51 | 4.41 | 4.8 | 4.87 | 4.03 | 4.42 | 4.49 | 4.87 | 4.42 | 4.93 | — |
Sep 2026: from the results filed on 29 Oct 2026, ahead of the full statement, so some rows are blank.
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8,273 | 8,424 | 9,268 | 9,847 | 10,314 | 9,911 | 11,029 | 12,276 | 13,316 | 14,096 | 13,997 | 15,178 | 15,949 |
| Expenses | 6,894 | 6,766 | 7,361 | 7,763 | 8,183 | 7,757 | 8,629 | 9,867 | 10,873 | 11,139 | 10,982 | 12,009 | 12,692 |
| Operating Profit | 1,379 | 1,657 | 1,907 | 2,084 | 2,132 | 2,154 | 2,399 | 2,409 | 2,443 | 2,957 | 3,015 | 3,169 | 3,257 |
| OPM % | 17% | 20% | 21% | 21% | 21% | 22% | 22% | 20% | 18% | 21% | 22% | 21% | 20% |
| Other Income | 73 | −262 | 76 | 283 | 362 | 32 | 23 | 78 | 114 | −2,209 | 252 | 33 | 11 |
| Interest | 112 | 128 | 154 | 173 | 238 | 228 | 138 | 122 | 188 | 310 | 361 | 344 | 331 |
| Depreciation | 91 | 101 | 142 | 156 | 170 | 197 | 204 | 210 | 236 | 241 | 234 | 268 | 283 |
| PBT | 1,249 | 1,167 | 1,687 | 2,039 | 2,085 | 1,760 | 2,080 | 2,155 | 2,133 | 198 | 2,672 | 2,590 | 2,653 |
| Tax % | 22% | 29% | 22% | 20% | −12% | 15% | 17% | 17% | 20% | 383% | 31% | 28% | — |
| Net Profit | 976 | 831 | 1,308 | 1,634 | 2,342 | 1,497 | 1,721 | 1,783 | 1,702 | −561 | 1,852 | 1,861 | 1,914 |
| EPS (₹) | 8.88 | 8.1 | 12.76 | 15.99 | 22.91 | 14.64 | 16.83 | 17.44 | 16.65 | −5.48 | 18.11 | 18.19 | 18.71 |
| Div. Payout % | 21% | 24% | 39% | 42% | 44% | 55% | 0% | 0% | 0% | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | 138% | 110% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 34 | 34 | 34 | 68 | 102 | 102 | 102 | 102 | 102 | 102 | 102 | 102 |
| Reserves | 4,277 | 4,233 | 5,268 | 6,190 | 7,165 | 7,796 | 9,337 | 11,454 | 13,692 | 12,496 | 11,897 | 12,546 |
| Borrowings | 2,717 | 2,891 | 4,001 | 3,508 | 3,382 | 3,575 | 1,864 | 1,704 | 1,130 | 3,222 | 4,009 | 4,421 |
| Other Liabilities | 2,097 | 2,521 | 3,637 | 4,098 | 3,445 | 3,407 | 2,941 | 2,822 | 2,513 | 2,571 | 3,289 | 3,873 |
| Total Liabilities | 9,125 | 9,679 | 12,940 | 13,864 | 14,094 | 14,880 | 14,244 | 16,082 | 17,437 | 18,392 | 19,298 | 20,942 |
| Fixed Assets | 5,551 | 5,931 | 8,083 | 8,315 | 8,670 | 9,231 | 8,905 | 9,219 | 9,934 | 10,440 | 10,676 | 12,556 |
| CWIP | 225 | 44 | 97 | 84 | 52 | 57 | 57 | 116 | 45 | 83 | 464 | 229 |
| Investments | 186 | 190 | 934 | 997 | 516 | 672 | 679 | 1,015 | 3,029 | 3,504 | 3,645 | 2,767 |
| Other Assets | 3,164 | 3,514 | 3,826 | 4,468 | 4,855 | 4,920 | 4,602 | 5,731 | 4,429 | 4,365 | 4,513 | 5,390 |
| Total Assets | 9,125 | 9,679 | 12,940 | 13,864 | 14,094 | 14,880 | 14,244 | 16,082 | 17,437 | 18,392 | 19,298 | 20,942 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 1,027 | 847 | 1,860 | 1,723 | 1,729 | 1,588 | 2,030 | 1,451 | 2,151 | 2,070 | 2,577 | 2,488 |
| Investing | −1,236 | −622 | −2,243 | −336 | 274 | −552 | −292 | −844 | −1,754 | −3,431 | −343 | 421 |
| Financing | −12 | −202 | 665 | −1,384 | −2,039 | −1,295 | −1,816 | −380 | −794 | 1,406 | −2,181 | −2,388 |
| Net Cash Flow | −221 | 23 | 282 | 3 | −36 | −259 | −79 | 227 | −398 | 45 | 52 | 522 |
| Free Cash Flow | 814 | 639 | 1,680 | 1,412 | 1,521 | 1,436 | 1,866 | 1,453 | 2,158 | 1,793 | 2,018 | 1,946 |
| CFO/OP | 93 | 71 | 119 | 102 | 102 | 90 | 101 | 79 | 105 | 83 | 101 | 95 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 36 | 48 | 41 | 46 | 46 | 43 | 33 | 33 | 34 | 40 | 47 | 44 |
| Inventory Days | 102 | 123 | 125 | 135 | 125 | 146 | 127 | 128 | 84 | 73 | 79 | 82 |
| Days Payable | 103 | 140 | 152 | 201 | 204 | 212 | 149 | 130 | 99 | 97 | 120 | 114 |
| Cash Conversion Cycle | 34 | 32 | 13 | −20 | −33 | −24 | 11 | 31 | 19 | 16 | 7 | 12 |
| Working Capital Days | −25 | −6 | −22 | −31 | −20 | −42 | −33 | −7 | −2 | −60 | −83 | −85 |
| ROCE % | 20% | 23% | 22% | 21% | 20% | 19% | 20% | 19% | 17% | 19% | 19% | 19% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Godrej Consumer Products insights
71 extracted metrics across FY05–FY27.
Documents
- Concall · Sep 2026Recording
- Q1 FY27 concall · Aug 2026Transcript Recording
- Q4 FY26 concall · May 2026Transcript PPT Recording
- Q3 FY26 concall · Jan 2026Transcript PPT Recording
- 20 Jul 2026
- 30 Apr 2026
- 9 Jul 2025
- 2 May 2025
- 10 May 2024
- General announcements 29 Oct 2026
- General announcements 29 Oct 2026
Frequently Asked Questions about Godrej Consumer Products
What does Godrej Consumer Products Ltd do?
Where is Godrej Consumer Products Ltd (GODREJCP) listed?
Which sector does Godrej Consumer Products Ltd belong to?
What is the PE ratio of Godrej Consumer Products Ltd?
What is the 52-week high and low of Godrej Consumer Products Ltd?
Does Godrej Consumer Products Ltd pay dividends?
What is the Return on Equity (ROE) of Godrej Consumer Products Ltd?
Company Information
Godrej Consumer Products is engaged in a fast moving consumer goods Company, manufacturing and marketing Household and Personal Care products.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/GODREJCP.md for Godrej Consumer Products Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.